Allspring Global Investments
IMPL

Allspring Global Investments’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Allspring Global Investments’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27,943
Closed -$177K – 3011
2022
Q1 		$177K Buy
27,943
+1,268
+5% +$9.58K ﹤0.01% 2605
2021
Q4 		$230K Buy
+26,675
New +$266K ﹤0.01% 2600

Other funds holding IMPL

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Allspring Global Investments's IMPL Position: Q2 2022 in Review

Allspring Global Investments sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q2 2022, closing a stake of 27,943 shares — an estimated $177K sold.

Allspring Global Investments first reported a position in IMPL in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q4 2021. 36 funds tracked by Wall St. Rank hold IMPL as of Q2 2022.

  • Allspring Global Investments reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 27,943 Impel Pharmaceuticals Inc. Common Stock shares in Q2 2022, an estimated $177K.
  • Allspring Global Investments first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Impel Pharmaceuticals Inc. Common Stock position peaked at $230K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.